Suchergebnisse - "Rendell, Marc S."

PubPharm (10)

1

Obesity and diabetes : the final frontier

enthalten in: Expert review of endocrinology & metabolism | 2023

von Rendell, M.

2

The journey from gene knockout to clinical medicine : telotristat and sotagliflozin

enthalten in: Drug design, development and therapy | 2019

von Rendell, M.

3

Efficacy and safety of sotagliflozin in treating diabetes type 1

enthalten in: Expert opinion on pharmacotherapy | 2018

von Rendell, M.

4

Albiglutide for the management of type 2 diabetes

enthalten in: Expert review of endocrinology & metabolism | 2018

von Rendell, M.

5

The safety of albiglutide for the treatment of type 2 diabetes

enthalten in: Expert opinion on drug safety | 2017

von Rendell, M.

6

Albiglutide : a unique GLP-1 receptor agonist

enthalten in: Expert opinion on biological therapy | 2016

von Rendell, M.

7

Glucagon-like polypeptide agonists in type 2 diabetes mellitus : efficacy and tolerability, a balance

enthalten in: Therapeutic advances in endocrinology and metabolism | 2015

von Tella, S. | Rendell, M.

8

DPP-4 inhibitors : focus on safety

enthalten in: Expert opinion on drug safety | 2015

von Tella, S. | Rendell, M.

9

Targeting postprandial hyperglycemia

enthalten in: Metabolism: clinical and experimental | 2006

von Rendell, M. | Jovanovic, L.

10

Manifestations of cutaneous diabetic microangiopathy

enthalten in: American journal of clinical dermatology | 2005

von Ngo, B. | Hayes, K. | DiMiao, D. | +3

1
[1]